Australia has one of the highest rates of food allergy, anaphylaxis hospital admissions and anaphylaxis fatalities worldwide. These trends and sustai…
The predisposition to food allergy development and the induction of allergen-specific immune responses appears to be initiated early in infancy. Earl…
The prevalence of allergic diseases across the Australian population, in all regions and age groups, is not well documented. This study aimed to desc…
The first peanut oral immunotherapy (OIT) for children was approved by the US Food and Drug Administration (FDA) in 2020. While clinical efficacy is…
The Australasian Society of Clinical Immunology and Allergy (ASCIA) Guideline: Infant Feeding for Food Allergy Prevention is an update of the 2016 AS…
Peanut allergy is the most common food allergy in Australian school-aged children and is rarely outgrown. Access to oral immunotherapy (OIT), a disea…
Food allergy affects families' quality of life, can be lifelong and life-threatening, urging the identification of early modifiable risk factors. For…
The high burden of peanut allergy underscores the need for treatment options that improve patient health-related quality of life (HRQL). However, the…
Peanut allergy is the most common childhood-onset, persistent food allergy. Peanut oral immunotherapy (OIT) is a potential treatment, but few studies…
Meta-analyses of randomized controlled trials have found that introducing eggs and peanuts earlier during infancy reduced egg and peanut allergy risk…